fidia spa (FDA:BrsaItaliana)
fidia spa (FDA) Snapshot
|
Open
€2.42
|
Previous Close
€2.45
|
|
|
Day High
€2.47
|
Day Low
€2.42
|
|
|
52 Week High
06/22/12 - €3.06
|
52 Week Low
07/23/12 - €2.07
|
|
|
Market Cap
12.7M
|
Average Volume 10 Days
9.1K
|
|
|
EPS TTM
€-0.44
|
Shares Outstanding
5.1M
|
|
|
EX-Date
04/2/03
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
fidia spa (FDA) Related Businessweek News
No Related Businessweek News Foundfidia spa (FDA) Details
FIDIA S.p.A. develops, manufactures, and sells numerical controls, drives, and milling machines primarily for the automotive, aerospace, and energy sectors. The company offers HSM machines, numerical controls, milling heads, and accessories, as well as computer aided manufacturing software for the cutting of complex shapes. It also provides technical support, training, and field services. The United States, Germany, France, Spain, China, Brazil, England, South Africa, Australia, India, south-east Asia, and Mexico Fidia S.p.A. was founded in 1974 and is headquartered in San Mauro, Italy.
fidia spa (FDA) Key Developments
FIDIA SpA announced consolidated and parent earnings results for the year ended December 31, 2012. For the year, on consolidated basis, the company reported net revenues of EUR 47,001,000 against EUR 36,422,000 a year ago. EBITDA was EUR 2,199,000 against EUR 2,588,000 a year ago. EBIT was EUR 1,383,000 against EUR 1,386,000 a year ago. EBT was EUR 1,172,000 against EUR 928,000 a year ago. Net income was EUR 324,000 against EUR 586,000 a year ago. Cash used in operating activities was EUR 4,142,000 against EUR 2,495,000 a year ago. For the year, on parent basis, the company reported net revenues of EUR 31,778,000 against EUR 26,233,000 a year ago. LBITDA was EUR 1,330,000 against EBITDA of EUR 9,000 a year ago. EBIT was EUR 38,000 against LBIT of EUR 766,000 a year ago. EBT was EUR 475,000 against LBT of EUR 301,000 a year ago. Net income was EUR 246,000 against net loss of EUR 246,000 a year ago. Cash used in operating activities was EUR 3,698,000 against EUR 663,000 a year ago.
FIDIA SpA announced that they will report fiscal year 2012 results on Mar 15, 2013
FIDIA SpA announced that they will report Q1, 2013 results on May 15, 2013
| Recently Viewed | |||
| FDA:IM | €2.47 EUR | +0.024 | |
| Company | Last | Change | |
| No competitor information is available for FDA. | |||
| View Industry Companies | |||
Industry Analysis
FDA
Industry Average
| Valuation | FDA | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.3x |
|
| Price/Book | 1.0x |
|
| Price/Cash Flow | 25.8x |
|
| TEV/Sales | NM | Not Meaningful |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact FIDIA SPA, please visit www.fidia.it. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








